BRAINSTORM CELL THERAPEUTICS INC. Financing Cash Flow
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Financing Cash Flow of $898.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $898.00K, a 66.75% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.25M, a 59.49% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $780.00K, a 26.28% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $313.00K.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2025 was $6.88M, a 13.64% decline from fiscal 2024.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2024 was $7.97M, a 58.02% decline from fiscal 2023.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2023 was $18.98M, a 7873.95% increase from fiscal 2022.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2022 was $238.00K, a 96.58% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 129 month | Net Cash Provided by (Used in) Financing Activities 132 month | Net Cash Provided by (Used in) Financing Activities 135 month | Net Cash Provided by (Used in) Financing Activities 138 month | Net Cash Provided by (Used in) Financing Activities 141 month | Net Cash Provided by (Used in) Financing Activities 144 month | Net Cash Provided by (Used in) Financing Activities 147 month | Net Cash Provided by (Used in) Financing Activities 150 month | Net Cash Provided by (Used in) Financing Activities 153 month | Net Cash Provided by (Used in) Financing Activities 156 month | Net Cash Provided by (Used in) Financing Activities 159 month | Net Cash Provided by (Used in) Financing Activities 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $898.00K 10-Q · filed 2026-08-14 | $2.15M 10-Q · filed 2026-08-14 | $2.93M derived: sum of 3 quarters · filed 2026-08-14 | $3.24M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-15 | $2.03M derived: sum of 2 quarters · filed 2026-05-15 | $2.34M derived: sum of 3 quarters · filed 2026-05-15 | $5.04M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-12-31 | $780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.09M derived: sum of 2 quarters · filed 2026-03-31 | $3.79M derived: sum of 3 quarters · filed 2026-08-14 | $6.88M 10-K · filed 2026-03-31 | ||||||||||||
| 2025-09-30 | $313.00K 10-Q · filed 2025-11-14 | $3.01M derived: sum of 2 quarters · filed 2026-08-14 | $6.10M 10-Q · filed 2025-11-14 | $7.16M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-06-30 | $2.70M 10-Q · filed 2026-08-14 | $5.79M 10-Q · filed 2026-08-14 | $6.84M derived: sum of 3 quarters · filed 2026-08-14 | $6.84M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-03-31 | $3.09M 10-Q · filed 2026-05-15 | $4.14M derived: sum of 2 quarters · filed 2026-05-15 | $4.14M derived: sum of 3 quarters · filed 2026-05-15 | $8.51M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2024-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.06M derived: sum of 2 quarters · filed 2026-03-31 | $5.43M derived: sum of 3 quarters · filed 2026-03-31 | $7.97M 10-K · filed 2026-03-31 | ||||||||||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $4.37M derived: sum of 2 quarters · filed 2025-11-14 | $6.91M 10-Q · filed 2025-11-14 | $10.26M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||
| 2024-06-30 | $4.37M 10-Q · filed 2025-08-14 | $6.91M 10-Q · filed 2025-08-14 | $10.26M derived: sum of 3 quarters · filed 2025-08-14 | $17.36M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||
| 2024-03-31 | $2.54M 10-Q · filed 2025-05-15 | $5.89M derived: sum of 2 quarters · filed 2025-05-15 | $12.99M derived: sum of 3 quarters · filed 2025-05-15 | $18.29M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $10.45M derived: sum of 2 quarters · filed 2025-03-31 | $15.75M derived: sum of 3 quarters · filed 2025-03-31 | $18.98M 10-K · filed 2025-03-31 | ||||||||||||
| 2023-09-30 | $7.10M 10-Q · filed 2024-11-14 | $12.40M derived: sum of 2 quarters · filed 2024-11-14 | $15.63M 10-Q · filed 2024-11-14 | |||||||||||||
| 2023-06-30 | $5.30M 10-Q · filed 2024-08-14 | $8.53M 10-Q · filed 2024-08-14 | ||||||||||||||
| 2023-03-31 | $3.23M 10-Q · filed 2024-05-14 | |||||||||||||||
| 2022-12-31 | $238.00K 10-K · filed 2024-04-01 | |||||||||||||||
| 2021-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$140.00K derived: sum of 2 quarters · filed 2023-03-30 | -$140.00K derived: sum of 3 quarters · filed 2023-03-30 | $6.97M 10-K · filed 2023-03-30 | ||||||||||||
| 2021-09-30 | -$106.00K 10-Q · filed 2022-11-14 | -$106.00K derived: sum of 2 quarters · filed 2022-11-14 | $7.00M 10-Q · filed 2022-11-14 | $27.94M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $7.11M 10-Q · filed 2022-08-15 | $28.05M derived: sum of 3 quarters · filed 2022-08-15 | $47.67M derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||
| 2021-03-31 | $7.11M 10-Q · filed 2022-05-16 | $28.05M derived: sum of 2 quarters · filed 2022-05-16 | $47.67M derived: sum of 3 quarters · filed 2022-05-16 | $55.09M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $20.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $40.57M derived: sum of 2 quarters · filed 2022-03-28 | $47.98M derived: sum of 3 quarters · filed 2022-03-28 | $76.94M 10-K · filed 2022-03-28 | ||||||||||||
| 2020-09-30 | $19.63M 10-Q · filed 2021-11-15 | $27.04M derived: sum of 2 quarters · filed 2021-11-15 | $56.00M 10-Q · filed 2021-11-15 | $58.06M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | $7.41M 10-Q · filed 2021-08-05 | $36.37M 10-Q · filed 2021-08-05 | $38.44M derived: sum of 3 quarters · filed 2021-08-05 | $41.59M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||
| 2020-03-31 | $28.96M 10-Q · filed 2021-04-26 | $31.02M derived: sum of 2 quarters · filed 2021-04-26 | $34.18M derived: sum of 3 quarters · filed 2021-04-26 | $34.18M derived: sum of 4 quarters · filed 2021-04-26 | ||||||||||||
| 2019-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $5.22M derived: sum of 2 quarters · filed 2021-02-04 | $5.22M derived: sum of 3 quarters · filed 2021-02-04 | $5.22M 10-K · filed 2021-02-04 | ||||||||||||
| 2019-09-30 | $3.16M 10-Q · filed 2020-10-15 | $3.16M derived: sum of 2 quarters · filed 2020-10-15 | $3.16M 10-Q · filed 2020-10-15 | $3.16M derived: sum of 4 quarters · filed 2020-10-15 | ||||||||||||
| 2019-06-30 | $5.00K 10-Q · filed 2020-08-05 | $5.00K 10-Q · filed 2020-08-05 | $5.00K derived: sum of 3 quarters · filed 2020-08-05 | $51.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-05-07 | $46.00K derived: sum of 3 quarters · filed 2020-05-07 | $12.04M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $46.00K derived: sum of 2 quarters · filed 2020-02-18 | $12.04M derived: sum of 3 quarters · filed 2020-02-18 | $12.06M 10-K · filed 2020-02-18 | ||||||||||||
| 2018-09-30 | $46.00K 10-Q · filed 2019-11-14 | $12.04M derived: sum of 2 quarters · filed 2019-11-14 | $12.06M 10-Q · filed 2019-11-14 | $12.27M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||||||
| 2018-06-30 | $11.99M 10-Q · filed 2019-08-13 | $12.02M 10-Q · filed 2019-08-13 | $12.23M derived: sum of 3 quarters · filed 2019-08-13 | $12.30M derived: sum of 4 quarters · filed 2019-08-13 | ||||||||||||
| 2018-03-31 | $25.00K 10-Q · filed 2019-05-10 | $234.00K derived: sum of 2 quarters · filed 2019-05-10 | $309.00K derived: sum of 3 quarters · filed 2019-05-10 | $339.00K derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||
| 2017-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $284.00K derived: sum of 2 quarters · filed 2019-04-01 | $314.00K derived: sum of 3 quarters · filed 2019-04-01 | $314.00K 10-K · filed 2019-04-01 | ||||||||||||
| 2017-09-30 | $75.00K 10-Q · filed 2018-10-29 | $105.00K derived: sum of 2 quarters · filed 2018-10-29 | $105.00K 10-Q · filed 2018-10-29 | |||||||||||||
| 2017-06-30 | $30.00K 10-Q · filed 2018-07-23 | $30.00K 10-Q · filed 2018-07-23 | ||||||||||||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 | |||||||||||||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-08 | |||||||||||||||
| 2015-03-31 | $14.74M 10-Q · filed 2015-05-14 | $14.79M derived: sum of 2 quarters · filed 2015-05-14 | $15.16M derived: sum of 3 quarters · filed 2015-05-14 | $24.43M derived: sum of 4 quarters · filed 2015-05-14 | ||||||||||||
| 2014-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $412.00K derived: sum of 2 quarters · filed 2015-03-26 | $9.69M derived: sum of 3 quarters · filed 2015-03-26 | $9.69M 10-K · filed 2015-03-26 | ||||||||||||
| 2014-09-30 | $366.00K 10-Q · filed 2014-11-13 | $9.64M derived: sum of 2 quarters · filed 2014-11-13 | $9.64M 10-Q · filed 2014-11-13 | $9.64M derived: sum of 4 quarters · filed 2015-05-14 | ||||||||||||
| 2014-06-30 | $9.27M 10-Q · filed 2014-08-12 | $9.27M 10-Q · filed 2014-08-12 | $9.27M derived: sum of 3 quarters · filed 2015-05-14 | $12.60M derived: sum of 4 quarters · filed 2015-05-14 | ||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $1.00K derived: sum of 2 quarters · filed 2015-05-14 | $3.33M derived: sum of 3 quarters · filed 2015-05-14 | $3.33M derived: sum of 4 quarters · filed 2015-05-14 | $23.21M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $3.33M derived: sum of 2 quarters · filed 2015-03-26 | $3.33M derived: sum of 3 quarters · filed 2015-03-26 | $3.58M 10-K · filed 2015-03-26 | $23.21M 10-K · filed 2014-03-27 | |||||||||||
| 2013-09-30 | $3.33M 10-Q · filed 2014-11-13 | $3.33M derived: sum of 2 quarters · filed 2014-11-13 | $3.58M 10-Q · filed 2014-11-13 | $3.58M derived: sum of 4 quarters · filed 2014-11-13 | $23.20M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $7.00K 10-Q · filed 2014-08-12 | $257.00K 10-Q · filed 2014-08-12 | $252.00K derived: sum of 3 quarters · filed 2014-08-12 | $5.28M derived: sum of 4 quarters · filed 2014-08-12 | $19.88M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $250.00K 10-Q · filed 2014-05-13 | $245.00K derived: sum of 2 quarters · filed 2014-05-13 | $5.27M derived: sum of 3 quarters · filed 2014-05-13 | $5.40M derived: sum of 4 quarters · filed 2014-05-13 | $19.87M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $5.02M derived: sum of 2 quarters · filed 2014-03-27 | $5.15M derived: sum of 3 quarters · filed 2014-03-27 | $5.17M 10-K · filed 2014-03-27 | $19.62M 10-K · filed 2013-03-14 | |||||||||||
| 2012-09-30 | $5.03M 10-Q · filed 2013-11-14 | $5.15M derived: sum of 2 quarters · filed 2013-11-14 | $5.17M 10-Q · filed 2013-11-14 | $5.20M derived: sum of 4 quarters · filed 2013-11-14 | $19.63M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $126.00K 10-Q · filed 2013-08-14 | $146.00K 10-Q · filed 2013-08-14 | $168.00K derived: sum of 3 quarters · filed 2013-08-14 | $557.00K derived: sum of 4 quarters · filed 2013-08-14 | $14.60M 10-Q/A · filed 2012-08-29 | |||||||||||
| 2012-03-31 | $20.00K 10-Q · filed 2013-05-09 | $42.00K derived: sum of 2 quarters · filed 2013-05-09 | $431.00K derived: sum of 3 quarters · filed 2013-05-09 | $475.00K derived: sum of 4 quarters · filed 2013-05-09 | $14.47M 10-Q · filed 2012-05-11 | |||||||||||
| 2011-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $411.00K derived: sum of 2 quarters · filed 2013-03-14 | $455.00K derived: sum of 3 quarters · filed 2013-03-14 | $4.12M 10-K · filed 2013-03-14 | $14.45M 10-K · filed 2012-03-15 | |||||||||||
| 2011-09-30 | $389.00K 10-Q · filed 2012-11-13 | $433.00K derived: sum of 2 quarters · filed 2012-11-13 | $4.09M 10-Q · filed 2012-11-13 | $3.98M derived: sum of 4 quarters · filed 2012-11-13 | $14.43M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $44.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $3.71M 10-Q/A · filed 2012-08-29 | $3.59M derived: sum of 3 quarters · filed 2012-08-29 | $4.02M derived: sum of 4 quarters · filed 2012-08-29 | $14.04M 10-Q/A · filed 2011-09-07 | |||||||||||
| 2011-03-31 | $3.66M 10-Q · filed 2012-05-11 | $3.55M derived: sum of 2 quarters · filed 2012-05-11 | $3.98M derived: sum of 3 quarters · filed 2012-05-11 | |||||||||||||
| 2010-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $313.00K derived: sum of 2 quarters · filed 2012-03-15 | $2.16M 10-K · filed 2012-03-15 | |||||||||||||
| 2010-09-30 | $426.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $2.27M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $1.85M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |